BTG
Live / Registered — Registered and renewed (as of 24 Jun 2021)
What this means for you
Registered since 12 Oct 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Oct 2020).
Record
- Serial number
- 77858442
- Registration number
- 3859364
- Mark type
- Design + words
- Filed
- 27 Oct 2009
- Published for opposition
- 27 Jul 2010
- Registered
- 12 Oct 2010
- Next maintenance due
- 12 Oct 2020
- Attorney of record
- Jonathan A. Hyman
Goods and services
- Class 001 — Chemicals: [ Chemicals used in science; chemicals for clinical research use; diagnostic reagents and substances for clinical and medical laboratory use; diagnostic reagents and substances for clinical and medical laboratory in vitro research use; polyclonal antibodies and fragments thereof for clinical research use; diagnostic reagents and substances for in vivo clinical and laboratory research use; chemical reagents for scientific research use; chemicals used in science and medicine, namely, adjuvant compositions for use in the manufacture of vaccines and antibodies and antibody fragments for use in diagnostics and assays; cell lines for use in production of whole cell derived vaccines; cell lines for use in research related to virus mediated disease ]
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances or sepsis; pharmaceutical preparations and substances for the treatment of thrombosis, [ inflammation, autoimmune disease and sleep disorders; dietetic foods adapted for medical use; ] vaccines; sera; polyclonal antibodies and fragments thereof for in vitro disease testing and for use in treating snake envenomation, overdose of toxic substances or sepsis; pharmaceutical preparations in the form of foams or for use in producing foams for use in sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins or arteriovenous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes, namely, for the treatment of and the diagnosis of the presence of toxic substances; pharmaceutical preparations for the treatment of cancer; [ pharmaceutical preparations for the reduction or elimination of circulating cytokines; pharmaceutical preparations for the treatment of neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of pain, including headache and migraine; ] pharmaceutical preparations for promoting the healing of dermal wounds and chronic wounds including ulcers and pressure sores; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical preparations for the treatment of envenomation with snake venom; pharmaceutical preparations for treatment of excess levels of cancer agents; pharmaceutical preparations for the treatment of toxic levels of other pharmaceutical agents; pharmaceutical preparations for the treatment of cytotoxic cancer treatment drug overdose, particularly overdose with methotrexate; [ pharmaceutical preparations for the treatment of sleep apnea; pharmaceutical preparations for the treatment of head lice; ] diagnostic reagents for medical use and for the determination of levels of toxic substances in blood and tissue samples in vitro
- Class 010 — Medical apparatus: Surgical apparatus for the treatment of varicose veins; medical syringes; cannula needles, medical tubing for administering drugs; surgical and medical apparatus for producing and administering pharmaceutical foams; surgical or medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for intravenous administration of pharmaceutical foam; diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose
- Class 042 — Scientific and technological services: [ Product research and development, namely, development of pharmaceuticals and medical devices through preclinical and clinical research in the fields of envenomation, drug overdose, chemical poisoning, venous disease, autoimmune disease, pain and inflammation and cancer therapy ]
Owner
- PROTHERICS MEDICINES DEVELOPMENT LIMITED, London, GB
- BTG International Limited, London, GB
- BTG International Limited, London, GB
- BTG International Limited, London, GB
Prosecution history
- 14 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED